Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. europe
  4. solid tumor
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Albania
  • Andorra
  • Austria
  • Belarus
  • Belgium
  • Bosnia & Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Faroe Islands
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Kosovo
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • Northern Ireland
  • Norway
  • Poland
  • Portugal
  • Romania
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Vatican City
Business Types

  • Manufacturer
  • Technology
  • Software vendor
  • Service provider
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Environmental
Employees

  • Over 1000
  • 101-1000

Solid Tumor Suppliers In Europe

37 companies found
In EuropeServing EuropeNear Europe

OSE Immunotherapeutics

OSE Immunotherapeutics

based inNantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
OSE - Model BI 765063 (OSE-172) - Tumor Microenvironment (TME)

OSE - Model BI 765063 (OSE-172) - Tumor Microenvironment (TME)

In recent years, immunotherapies have driven significant clinical progress and increased hopes for patients suffering from various types of cancer. The tumor microenvironment (TME), in particular the presence and immune-status of myeloid derived ...
CONTACT SUPPLIER

BetaGlue Technologies SpA

BetaGlue Technologies SpA

based inMilano, ITALY
BetaGlue Technologies can deliver a localized amount of energy via a simple, intra-operative, internal radiotherapy platform engineered to achieve maximum efficacy and much improved safety for the patients. A new anti-tumoral compound based on 90Y ...
BetaGlue - Anti-Tumoral Compound

BetaGlue - Anti-Tumoral Compound

Surgery is the standard of care for resectable solid tumors. Loco-regional approaches, in combination with chemotherapy and/or radiotherapy, are standard therapy in the following ...
CONTACT SUPPLIER

OncoDNA S.A.

OncoDNA S.A.

based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
OncoSELECT - Cancer-Specific Biomarker Test Kit on a Liquid Biopsy

OncoSELECT - Cancer-Specific Biomarker Test Kit on a Liquid Biopsy

OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
CONTACT SUPPLIER

ITM Isotope Technologies Munich SE

ITM Isotope Technologies Munich SE

based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
Targeted Radionuclide Therapy Services

Targeted Radionuclide Therapy Services

Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once ...
CONTACT SUPPLIER

Sartorius AG

Sartorius AG

based inGoettingen, GERMANY
We provide the essential products, technologies and expertise to produce biopharmaceuticals reliably and efficiently. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all ...
Veltis - Technology

Veltis - Technology

Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
CONTACT SUPPLIER

CDR-Life

CDR-Life

based inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
Antibody Therapies

Antibody Therapies

CDR-Life’s pipeline is based on it’s unique antibody fragment platform. It includes a series of highly cancer-targeted and drug-based immunotherapies against intracellular tumor antigens for treatment of a variety of ...
CONTACT SUPPLIER

ORYX GmbH & Co. KG

ORYX GmbH & Co. KG

based inBaldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
VicOryx - Model p16 - Therapeutic Vaccine

VicOryx - Model p16 - Therapeutic Vaccine

The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers associated with ...
CONTACT SUPPLIER

Brenus Pharma

Brenus Pharma

based inIssoire, FRANCE
An allogeneic platform designed to generate first in class immune therapy with the goal of harnessing the patient immune system and preventing resistance to cancer treatment. Our mission at Brenus is to provide a solution to cold solid tumors – ...
CONTACT SUPPLIER

Genmab A/S

Genmab A/S

based inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Genmab DuoBody - Model CD3xB7H4 (GEN1047) - Proprietary Bispecific Antibody

Genmab DuoBody - Model CD3xB7H4 (GEN1047) - Proprietary Bispecific Antibody

DuoBody-CD3xB7H4 (GEN1047) is a proprietary bispecific antibody created using Genmab’s DuoBody® technology. B7H4 is an immune checkpoint protein expressed on malignant cells in various solid cancers including breast, ...
CONTACT SUPPLIER

Rarecells Diagnostics SAS

Rarecells Diagnostics SAS

based inParis Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
Rarecells ISET - Isolation by SizE of Tumor Cells Technology

Rarecells ISET - Isolation by SizE of Tumor Cells Technology

ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority ...
CONTACT SUPPLIER

Exosome Diagnostics, Inc.

Exosome Diagnostics, Inc.

based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
CONTACT SUPPLIER

T3 Pharmaceuticals AG

T3 Pharmaceuticals AG

based inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Proprietary Platform for Protein Delivery

Proprietary Platform for Protein Delivery

T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where ...
CONTACT SUPPLIER

T-Knife GmbH

T-Knife GmbH

based inBerlin, GERMANY
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer. The company is initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a promising modality that holds the ...
Model TK-8001 - TCR-T Targeting MAGE-A1 Positive Solid Tumors

Model TK-8001 - TCR-T Targeting MAGE-A1 Positive Solid Tumors

TK-8001 is a CD8 TCR-T specific for the Melanoma-associated Antigen Gene-A1, or MAGE-A1. MAGE-A1 is associated with hallmarks of aggressive cancers and poor clinical prognosis, and there is an emerging body of evidence indicating its involvement as ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
PsiOxus - Model T-SIGn - Viral Vector Platform Technology

PsiOxus - Model T-SIGn - Viral Vector Platform Technology

Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to ...
CONTACT SUPPLIER

AC BioScience SA

AC BioScience SA

based inEpalinges, SWITZERLAND
AC BioScience Ltd., a clinical-stage biotech company and a developer of immune modulating and angiogenic cancer therapies. AC BioScience LTD. is a Swiss biotech company, pioneering the development of novel therapies in immuno-oncology and tumor ...
Model ACB2003.4 - Sphingosine 1-Phosphate Lyase Inhibitor

Model ACB2003.4 - Sphingosine 1-Phosphate Lyase Inhibitor

Our medical objective is to validate and bring to clinical use, a novel approach to improve the treatment of metastatic pancreatic adenocarcinoma using a proangiogenic molecule S1P lyase inhibitor acting as a tumor vascular ...
CONTACT SUPPLIER

Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc.

Theriva Biologics, Inc., formely known as ynthetic Biologics, Inc.

based inRockville, MARYLAND (USA)
Theriva™ is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Our developmental therapies stem from the laboratory of Dr. ...
Hyaluronidase Technology

Hyaluronidase Technology

Solid tumors are complex organ-like structures consisting of cancer cells, vasculature, and tumor matrix. This dense extracellular matrix, also known as stroma, hampers the intratumoral ...
CONTACT SUPPLIER

The Menarini Group

The Menarini Group

based inFlorence, ITALY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...
Model MEN1309 - Antibody-Drug Conjugate (ADC)

Model MEN1309 - Antibody-Drug Conjugate (ADC)

MEN1309 is an antibody-drug conjugate (ADC) constituted by a fully human IgG1 antibody conjugated through a cleavable linker to a cytotoxic agent (a maytansin derivative, DM4), responsible for its antitumor activity. The target antigen, CD205, is ...
CONTACT SUPPLIER

Immudex ApS

Immudex ApS

based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Dextramer - In Situ Staining

Dextramer - In Situ Staining

Visualize the Landscape of Tissue-Specific Immunity. Tracking T cells in the tissue where they exert their function can advance our understanding of T-cell immunity. MHC I Dextramer® for in-situ staining reagents can detect spatial distribution, ...
CONTACT SUPPLIER

Kiadis Pharma NV

Kiadis Pharma NV

based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
Model K-NK002 - NK Cells for Cancer Immunotherapeutics

Model K-NK002 - NK Cells for Cancer Immunotherapeutics

K-NK002: A phase 2 clinical study evaluating haplo-identical NK cells to prevent post-transplant relapse in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This study was designed based on promising clinical ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT